AARTI PHARMALABS LIMITED vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of AARTI PHARMALABS LIMITED (AARTIPHARM) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads AARTIPHARM vs ZYDUSLIFE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.74
P/E ratio
22.83
2.98
P/B ratio
4.09
0.21%
Dividend yield
0.09%
₹19.27
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

8.59%
Return on equity
21.20%
11.00%
Return on capital
21.00%
20.00%
EBITDA margin
31.00%
9.62%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-2.21%
Revenue CAGR (3Y)
16.35%
-3.21%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹6,409 Cr
Market cap
₹1.15L Cr
₹1,819 Cr
Revenue
₹27,148 Cr
₹175 Cr
Net profit
₹5,124 Cr
0.35
Debt / equity
0.46
AARTI PHARMALABS LIMITED
  • ["Stock is trading at 3.03 times its book value", "Company has a low return on equity of 11.9% over last 3 years."]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
AARTI PHARMALABS LIMITED full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

AARTI PHARMALABS LIMITED vs ZYDUS LIFESCIENCES LTD: Share Price, Valuation & Which to Buy | DocStoX